Outcomes in patients with fungal endocarditis: A multicenter observational cohort study

Int J Infect Dis. 2018 Dec:77:48-52. doi: 10.1016/j.ijid.2018.09.016. Epub 2018 Sep 21.

Abstract

Objective: To compare the clinical and epidemiological features, treatments, and outcomes of patients with isolated right-sided and left-sided fungal endocarditis and to determine the risk factors for in-hospital mortality in patients with Candida sp endocarditis.

Methods: A retrospective review of all consecutive cases of fungal endocarditis from five hospitals was performed. Clinical features were compared between patients with isolated right-sided and left-sided endocarditis. In the subgroup of fungal endocarditis due to Candida species, binary logistic regression analysis was performed to determine variables related to in-hospital mortality.

Results: Seventy-eight patients with fungal endocarditis were studied. Their median age was 50 years; 55% were male and 19 patients (24%) had isolated right-sided endocarditis. Overall, cardiac surgery was performed in 46 patients (59%), and in-hospital mortality was 54%. Compared to patients with left-side fungal endocarditis, patients with isolated right-sided endocarditis had lower mortality (32% vs. 61%; p=0.025) and were less often submitted to cardiac surgery (37% vs. 66%; p=0.024). The most frequent etiology was Candida spp (85%). In this subgroup, acute heart failure (odds ratio 5.0; p=0.027) and exclusive medical treatment (odds ratio 11.1; p=0.004) were independent predictors of in-hospital death, whereas isolated right-sided endocarditis was related to a lower risk of mortality (odds ratio 0.13; p=0.023).

Conclusions: Patients with isolated right-sided fungal endocarditis have particular clinical and epidemiological features. They were submitted to cardiac surgery less often and had better survival than patients with left-sided fungal endocarditis. Isolated right-sided endocarditis was also a marker of a less harmful illness in the subgroup of Candida sp endocarditis.

Keywords: Candida; Endocarditis; Fungi.

Publication types

  • Multicenter Study
  • Observational Study

MeSH terms

  • Adult
  • Amphotericin B / therapeutic use
  • Antifungal Agents / therapeutic use
  • Candida / drug effects
  • Candida / isolation & purification
  • Echinocandins / therapeutic use
  • Endocarditis / drug therapy
  • Endocarditis / mortality*
  • Female
  • Fluconazole / therapeutic use
  • Follow-Up Studies
  • Heart Failure / drug therapy
  • Heart Failure / microbiology
  • Heart Failure / mortality*
  • Hospital Mortality
  • Humans
  • Male
  • Middle Aged
  • Mycoses / drug therapy
  • Mycoses / mortality*
  • Retrospective Studies
  • Risk Factors
  • Treatment Outcome

Substances

  • Antifungal Agents
  • Echinocandins
  • Amphotericin B
  • Fluconazole